(Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 603.96%196.7K | 48.81%5.9K | -96.41%5.42K | -90.01%25.24K | -90.01%25.24K | 309.05%27.94K | -98.51%3.96K | -63.28%151.11K | 2,449.47%252.75K | 2,449.47%252.75K |
-Cash and cash equivalents | 690.54%195.2K | 447.19%3.9K | -97.99%2.92K | -90.62%23.24K | -90.62%23.24K | 1,248.55%24.69K | -99.73%712 | -64.16%145.61K | 10,163.21%247.75K | 10,163.21%247.75K |
-Accounts receivable | --134.39K | --33.68K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other receivables | --258.43K | --275.9K | --273.3K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total current assets | 186.81%641.09K | 123.33%52.08K | -72.15%64.04K | -73.64%112.74K | -73.64%112.74K | -40.45%223.52K | -91.89%23.32K | -51.21%229.92K | 2,185.38%427.75K | 2,185.38%427.75K |
Non current assets | ||||||||||
Regulatory assets | 201.46%134.39K | 74.00%33.68K | -2.30%8.61K | ---- | ---- | -25.36%44.58K | 45.34%19.36K | -34.49%8.82K | ---- | ---- |
Total assets | ---- | ---- | -2.30%8.61K | ---- | ---- | -25.36%44.58K | 45.34%19.36K | -34.49%8.82K | ---- | ---- |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | 7.87%1.16M | 12.51%1.11M | 18.72%1.11M | 17.55%1.09M | 17.55%1.09M | 17.71%1.07M | 12.69%987.54K | -8.92%935.35K | -9.48%925.74K | -9.48%925.74K |
-Current debt | 7.87%1.16M | 12.51%1.11M | 18.72%1.11M | 17.55%1.09M | 17.55%1.09M | 17.71%1.07M | 12.69%987.54K | -8.92%935.35K | -9.48%925.74K | -9.48%925.74K |
-accounts payable | 35.13%1.25M | 46.93%1.22M | 54.82%1.06M | 74.30%1.21M | 74.30%1.21M | 22.34%923.61K | 8.79%833.7K | -38.96%687.78K | -41.81%692.86K | -41.81%692.86K |
-Total tax payable | --0 | --0 | --0 | --0 | --0 | -62.69%137.79K | -46.44%197.79K | --287.79K | --317.79K | --317.79K |
Current accrued expenses | 64.71%211.9K | 94.04%175.9K | 65.70%159.9K | 121.48%194.9K | 121.48%194.9K | -42.50%128.65K | -63.11%90.65K | -58.63%96.5K | -56.39%88K | -56.39%88K |
Current liabilities | 34.19%2.89M | 42.97%2.8M | 53.58%2.63M | 47.93%2.56M | 47.93%2.56M | 13.76%2.15M | -46.58%1.96M | -57.57%1.71M | -60.13%1.73M | -60.13%1.73M |
Non current liabilities | ||||||||||
Non current accrued expenses | --0 | -64.92%78.7K | 7.62%214.53K | 7.62%214.53K | 7.62%214.53K | 117.08%224.35K | 179.91%224.35K | 148.72%199.35K | 148.72%199.35K | 148.72%199.35K |
Total non current liabilities | 26.11%2.89M | 29.85%2.8M | 31.51%2.63M | 25.00%2.56M | 25.00%2.56M | 1.27%2.29M | -46.57%2.15M | -50.45%2M | -52.81%2.05M | -52.81%2.05M |
Shareholders'equity | ||||||||||
Share capital | 10.45%12.56M | 6.12%11.75M | 6.36%11.75M | 4.37%11.37M | 4.37%11.37M | 2.50%11.37M | 22.74%11.07M | 24.37%11.05M | 37.19%10.9M | 37.19%10.9M |
-common stock | 10.45%12.56M | 6.12%11.75M | 6.36%11.75M | 4.37%11.37M | 4.37%11.37M | 2.50%11.37M | 22.74%11.07M | 24.37%11.05M | 37.19%10.9M | 37.19%10.9M |
Additional paid-in capital | 6.38%3.21M | 17.59%3.21M | 17.59%3.21M | 17.44%3.21M | 17.44%3.21M | 15.87%3.02M | 5.97%2.73M | 6.19%2.73M | 29.29%2.73M | 29.29%2.73M |
Gains losses not affecting retained earnings | 0.00%-378.35K | 0.00%-378.35K | 0.00%-378.35K | 0.00%-378.35K | 0.00%-378.35K | 19.39%-378.35K | 19.39%-378.35K | -2.17%-378.35K | 0.00%-378.35K | 0.00%-378.35K |
Other equity interest | ---- | ---- | ---- | ---- | ---- | --1K | ---- | ---- | ---- | ---- |
Total equity | 43.46%641.09K | -47.20%130.78K | -35.11%278.57K | -47.81%327.27K | -47.81%327.27K | -6.65%446.87K | -32.65%247.67K | -22.15%429.27K | 534.29%627.1K | 534.29%627.1K |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.